Back to Journals » OncoTargets and Therapy » Volume 10

Phase I dose-escalation study of long-acting pasireotide in patients with neuroendocrine tumors

Total article views   HTML views PDF downloads Totals
14,595 Dovepress* 13,979+ 1,236 15,215
PubMed Central* 616 217 833
Totals 14,595 1,453 16,048
*Since 27 June 2017
Total mentioned Facebook Delicious Reddit Twitter Others
2 0 0 0 1 1

View citations on PubMed Central and Google Scholar